Alnylam Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 205.48 USD | 495,55 USD | 197,81 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 432,044 USD | 15 | 7 | 8 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 133.512.573 | 5,77 | 3,62 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Alnylam Pharmaceuticals Inc
Mitarbeiter 2.500
Handelsplatz NASDAQ
Ticker Symbol ALNY
IPO Datum 2004-05-28
Adresse 675 West Kendall Street, Cambridge, MA, United States, 02142
Webseite https://www.alnylam.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Yvonne L. Greenstreet M.B.A., M.D. | CEO & Director |
| 2 | Dr. Phillip A. Sharp Ph.D. | Co-Founder, Member of the Scientific Advisory Board |
| 3 | Mr. Jeffrey V. Poulton M.B.A. | CFO & Executive VP |
| 4 | Mr. Bryan Andrew Supran J.D. | Chief Legal Officer |
| 5 | Dr. Pushkal P. Garg M.D. | Executive VP & Chief Research & Development Officer |
| 6 | Mr. Tolga Tanguler M.B.A. | Executive VP & Chief Commercial Officer |
| 7 | Mr. Timothy J. Maines | Chief Technical Operations & Quality Officer |
| 8 | Dr. Kevin Joseph Fitzgerald Ph.D. | Executive VP, Chief Scientific Officer and Head of Early Research & Early Development |
| 9 | Mr. Piyush Sharma J.D. | Chief Ethics & Compliance Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | Capital World Investors | 0,00% | 0,00 Mio. USD |
| 4 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 5 | Capital Research Global Investors | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 10 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 11 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 12 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Baillie Gifford & Co Limited. | 0,00% | 0,00 Mio. USD |
| 14 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 15 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 16 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 17 | Dodge & Cox | 0,00% | 0,00 Mio. USD |
| 18 | American Century Companies Inc | 0,00% | 0,00 Mio. USD |
| 19 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 20 | ClearBridge Advisors, LLC | 0,00% | 0,00 Mio. USD |